The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Dapsone in dermatology and beyond
Open accessAbstract
Dapsone (4,4'-diaminodiphenylsulfone) is an aniline derivative belonging to the group of synthetic sulfones. In 1937 against the background of sulfonamide era the microbial activity of dapsone has been discovered. Shortly thereafter, the use of dapsone to treat non-pathogen-caused diseases revealed alternate antiinflammatory mechanisms that initially were elucidated by inflammatory animal models. Thus, dapsone clearly has dual functions of both: antimicrobial/antiprotozoal effects and anti-inflammatory features similarly to non-steroidal anti-inflammatory drugs. The latter capabilities primarily were used in treating chronic inflammatory disorders. Dapsone has been investigated predominantly by in vitro methods aiming to get more insights into the effect of dapsone to inflammatory effector cells, cytokines, and/or mediators, such as cellular toxic oxygen metabolism, myoloperoxidase-/halogenid system, adhesion molecules, chemotaxis, membrane-associated phospholipids, prostaglandins, leukotrienes, interleukin-8, tumor necrosis factor α, lymphocyte functions, and tumor growth. Moreover, attention has been paid to mechanisms by which dapsone mediates effects in more complex settings like impact of lifespan, stroke, glioblastoma, or as anticonvulsive agent. Additionally, there are some dermatological investigations in human being using dapsone and its metabolites (e.g., leukotriene B4-induced chemotaxis, ultraviolet-induced erythema). It could be established that dapsone metabolites by their own have anti-inflammatory properties. Pharmacology and mechanisms of action are determining factors for clinical use of dapsone chiefly in neutrophilic and/or eosinophilic dermatoses and in chronic disorders outside the field of dermatology. The steroid-sparing effect of dapsone is useful for numerous clinical entities. Future avenues of investigations will provide more information on this fascinating and essential agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,631
Managing the challenge of chemically reactive metabolites in drug development
Park, B. K., Boobis, A., Clarke, S., Goldring, C. E. P., Jones, D., Kenna, J. G., Lambert, C., Laverty, H. G., Naisbitt, D. J., Nelson, S., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3408 · Cited by 462
Dapsone and sulfones in dermatology: Overview and update
Zhu, Y. I., & Stiller, M. J. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114733 · Cited by 441
Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics
Strom, B. L., Schinnar, R., Apter, A. J., Margolis, D. J., Lautenbach, E., Hennessy, S., Bilker, W. B., & Pettitt, D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022963 · Cited by 349
Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation.
Mukaida, N. (2000) · PubMed · Cited by 315
THE EFFECT OF ANTIMICROBIAL AGENTS ON LEUKOCYTE CHEMOTAXIS
Esterly, N. B., Furey, N. L., & Flanagan, L. E. (1978) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12543487 · Cited by 254
Clinical Pharmacokinetics of Dapsone
Zuidema, J., Modderman, E. S. M., & Merkus, F. W. H. M. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611040-00003 · Cited by 252
Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood.
DeForge, L. E., Fantone, J. C., Kenney, J. S., & Remick, D. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116097 · Cited by 233
Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance
COLEMAN, M. D. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb00476.x · Cited by 214
Neutrophilic Dermatoses: A Review of Current Treatment Options
Cohen, P. R. (2009) · American Journal of Clinical Dermatology · doi:10.2165/11310730-000000000-00000 · Cited by 196
The Pathophysiology of Bullous Pemphigoid
Kasperkiewicz, M., & Zillikens, D. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-0030-y · Cited by 192
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs
Kettle, A. J., & Winterbourn, C. C. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90565-m · Cited by 185
The Inhibition of Polymorphonuclear Leukocyte Cytotoxicity by Dapsone
Stendahl, O., Molin, L., & Dahlgren, C. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109109 · Cited by 177
Dapsone Suppresses Integrin-Mediated Neutrophil Adherence Function
Booth, S. A., Moody, C. E., Dahl, M. V., Herron, M. J., & Nelson, R. D. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12555654 · Cited by 172
Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.
Xia, M., Qin, S., McNamara, M. J., Mackay, C. R., & Hyman, B. T. (1997) · Europe PMC (PubMed Central) · Cited by 131
Draelos, Z. D., Carter, E., Maloney, J. M., Elewski, B. E., Poulin, Y. P., Lynde, C. W., & GARRETT, S. J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.005 · Cited by 126
Comparison of the Metabolism and Toxicity of Dapsone in Rat, Mouse and Man
Tingle, M. D., Mahmud, R., Maggs, J. L., Pirmohamed, M., & Park, B. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37079-x · Cited by 125
Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients
Yazdanyar, S., Boer, J., Ingvarsson, G., Szepietowski, J. C., & Jemec, G. B. E. (2011) · Dermatology · doi:10.1159/000329023 · Cited by 121
Bissinger, E.-M., Heinke, R., Spannhoff, A., Eberlin, A., Metzger, E., Cura, V., Hassenboehler, P., Cavarelli, J., Schüle, R., Bedford, M. T., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.032 · Cited by 112
Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone
Bozeman, P. M., Learn, D. B., & Thomas, E. L. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90449-s · Cited by 105
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo*
Mitra, A., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., & Slattcry, J. T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90176-0 · Cited by 104
Sulfone therapy in the treatment of leukocytoclastic vasculitis
Fredenberg, M. F., & Malkinson, F. D. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70100-5 · Cited by 94
Kettle, A. J., Gedye, C. A., & Winterbourn, C. C. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90010-t · Cited by 94
Dapsone toxicity: Some current perspectives
Coleman, M. D. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00029-1 · Cited by 92
Bloody Diarrhea—A Possible Complication of Sulfasalazine Transferred Through Human Breast Milk
Branski, D., Kerem, E., Gross‐Kieselstein, E., Hurvitz, H., Litt, R., & Abrahamov, A. (1986) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-198603000-00028 · Cited by 84
Israili, Z. H., Cucinell, S. A., Vaught, J., Davis, E., Lesser, J., & Dayton, P. G. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29658-6 · Cited by 84
Niwa, Y., Sakane, T., & Miyachi, Y. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90705-6 · Cited by 81
Prussick, R. B. (1992) · Archives of Dermatology · doi:10.1001/archderm.1992.01680120082007 · Cited by 77
Kim, S. M., Kim, D., Jeong, C. H., Kim, D. H., Kim, J. H., Jeon, H. B., Kwon, S., Jeun, S., Yang, Y. S., Oh, W., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.093 · Cited by 76
Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges
Nicholas, M. K., Lukas, R. V., Chmura, S. J., Yamini, B., Lesniak, M. S., & Pytel, P. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.01.009 · Cited by 75
Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system
van Zyl, J. M., Basson, K., Kriegler, A., & van der Walt, B. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90323-w · Cited by 74
Harvath, L., Yancey, K. B., & Katz, S. I. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.4.1305 · Cited by 67
Bloody Diarrhea—A Possible Complication of Sulfasalazine Transferred Through Human Breast Milk
Branski, D., Kerem, E., Gross‐Kieselstein, E., et al. (1986) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-198605020-00028 · Cited by 67
Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy
Hargrave, D. R. (2009) · British Journal of Neurosurgery · doi:10.1080/02688690903158809 · Cited by 59
Díaz-Ruiz, A., Zavala, C., Montes, S., Ortíz-Plata, A., Salgado‐Ceballos, H., Orozco-Suárez, S. A., Nava-Ruíz, C., Pérez‐Neri, I., Pérez‐Severiano, F., & Ríos, C. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21775 · Cited by 56
Dapsone is safe during pregnancy
Kahn, G. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)80416-3 · Cited by 55
DDS, 4,4′-diaminodiphenylsulfone, extends organismic lifespan
Cho, S. C., Park, M. C., Keam, B., Choi, J. M., Cho, Y., Hyun, S., Park, S. C., & Lee, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005078107 · Cited by 55
Kanoh, S., Tanabe, T., & Rubin, B. K. (2011) · CHEST Journal · doi:10.1378/chest.10-2908 · Cited by 55
Theron, A. J., & Anderson, R. (1985) · PubMed · doi:10.1164/arrd.1985.132.5.1049 · Cited by 54
Dapsone: unapproved uses or indications
Wolf, R., Tüzün, B., & Tüzün, Y. (2000) · Clinics in Dermatology · doi:10.1016/s0738-081x(99)00093-0 · Cited by 51
Elastase, a marker for neutrophils in skin infiltrates
Lammers, A. M., van de Kerkhof, P. C. M., SCHALWIJK, J., & MIER, P. D. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb05715.x · Cited by 50
Dapsone-induced photodermatitis in a patient with linear IgA dermatosis.
Stöckel, S., Meurer, M., & Wozel, G. (2001) · PubMed · Cited by 44
Self-citationMiyachi, Y., & Niwa, Y. (1983) · Archives of Dermatological Research · doi:10.1007/bf00516550 · Cited by 36
Protective effect of 4,4'-diaminodiphenylsulfone against paraquat-induced mouse lung injury
Cho, S. C., Rhim, J. H., Choi, H. R., Son, Y. H., Lee, S. J., Song, K.-Y., & Park, S. C. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.9.060 · Cited by 35
Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats
os, C. R. X., Nader, J. A., Rodriguez-Payán, A. J., & Nava-Ruíz, C. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.040 · Cited by 31
NEONATAL HÆMOLYTIC DISEASE DUE TO DAPSONE
Hocking, D. R. (1968) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1968.tb29209.x · Cited by 31
Vitamin E and Dapsone-Induced Hemolysis
Kelly, J. W. (1984) · Archives of Dermatology · doi:10.1001/archderm.1984.01650480044015 · Cited by 30
The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment
Kast, R. E., Scheuerle, A., Wirtz, C. R., Karpel‐Massler, G., & Halatsch, M. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011797378805 · Cited by 29
Why dapsone stops seizures and may stop neutrophils’ delivery of VEGF to glioblastoma
Kast, R. E., Lefranc, F., Karpel‐Massler, G., & Halatsch, M. (2012) · British Journal of Neurosurgery · doi:10.3109/02688697.2012.674577 · Cited by 28
The Reduction of Methemoglobin Levels by Antioxidants
Stratton, L. P., Rudolph, A. S., Knoll, W. K., Bayne, S., & Farmer, M. C. (1988) · Hemoglobin · doi:10.3109/03630268808998035 · Cited by 28
Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver
Veggi, L. M., Pretto, L., Ochoa, E. J., Catania, V. A., Luquita, M. G., Taborda, D. R., Pozzi, E. J. S., Ikushiro, S., Coleman, M. D., Roma, M. G., et al. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.05.016 · Cited by 27
Khan, F. D., Roychowdhury, S., Nemes, R., Vyas, P. M., Woster, P. M., & Svensson, C. K. (2005) · Toxicology · doi:10.1016/j.tox.2005.10.002 · Cited by 24
WEBSTER, G. F. (2010) · PubMed · Cited by 23
Hashimoto, K., Singer, K. H., & Lazarus, G. S. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb04634.x · Cited by 21
Bordin, L., Fiore, C., Zen, F., Coleman, M. D., Ragazzi, E., & Clari, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00962.x · Cited by 20
Dapsone‐induced photosensitivity: a rare clinical presentation
Kar, B. R. (2008) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2008.00372.x · Cited by 19
Cho, S. C., Rhim, J. H., Son, Y. H., Lee, S. J., & Park, S. C. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.3.024 · Cited by 17
Mochida, O., Matsumoto, T., Mizunoe, Y., et al. (1997) · Chemotherapy · doi:10.1159/000007088 · Cited by 11
Inhibitory effects of dapsone on enzymatic activities of membrane phospholipids in human blood cells
Niwa, Y., & Miyachi, Y. (1985) · Archives of Dermatological Research · doi:10.1007/bf00510065 · Cited by 7
Wozel, G., Blümlein, K., Blasum, C., Lehmann, B., & Winter, C. (1999) · Chemotherapy · doi:10.1159/000007188 · Cited by 6
Self-citationTherapeutische Alternativen bei Antihistamintherapie-refraktärer Urtikaria
Maurer, M., Altrichter, S., Ardelean, E., Krause, K., Magerl, M. A. K., Metz, M., Siebenhaar, F., Weller, K., & Zuberbier, T. (2010) · Der Hautarzt · doi:10.1007/s00105-010-1934-7 · Cited by 4
Cited by
Drug repurposing: a promising tool to accelerate the drug discovery process
Parvathaneni, V., Kulkarni, N. S., Muth, A., & Gupta, V. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.014 · Cited by 597
Fox, L., Csongradi, C., Aucamp, M., Du Plessis, J., & Gerber, M. (2016) · Molecules · doi:10.3390/molecules21081063 · Cited by 339
Hofman, K., Liu, N., & Manolikakes, G. (2018) · Chemistry – A European Journal · doi:10.1002/chem.201705470 · Cited by 283
In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria
Blaskovich, M. A. T., Elliott, A. G., Kavanagh, A. M., Ramu, S., & Cooper, M. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50746-4 · Cited by 89
Metadata
- Authors
- Wozel, G., & Blasum, C.
- Venue
- Archives of Dermatological Research
- Published
- 2013-12-06
- Volume
- 306
- Issue
- 2
- Pages
- 103-124
- ISSN
- 0003-9187 (ISSN-L)
- 0340-3696
- 1432-069X
- OpenAlex
- W1976064605
- Cited by
- 346
- References
- 62
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.